C8G Human

Complement Component 8, Gamma Human Recombinant
Cat. No.
BT17812
Source
E.coli.
Synonyms
Complement component 8 gamma polypeptide, C8C, complement component C8 gamma chain, MGC142186.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

C8G Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 203 amino acids (21-202) and having a molecular mass of 22.6 kDa.
The C8G is fused to a 21 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
C8, an element of the complement system, comprises three polypeptides: C8A, C8B, and C8G. This component plays a crucial role in forming the Membrane Attack Complex (MAC). Individuals deficient in C8 are susceptible to various bacterial infections. C8G, belonging to the lipocalin family and calycin superfamily, functions as a secreted protein capable of binding retinol. Produced in the liver, monocytes, and fibroblasts, C8G contributes to eliminating pathogens from an infected host.
Description
Recombinant human C8G, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 203 amino acids (21-202). It possesses a molecular mass of 22.6 kDa. For purification purposes, a 21 amino acid His-Tag is fused to the N-terminus of C8G, and proprietary chromatographic techniques are employed.
Physical Appearance
A clear, sterile solution without any color.
Formulation
The C8G solution has a concentration of 0.5mg/ml and is prepared in a buffer containing 20mM Tris-HCl (pH 8.0), 2mM DTT, 0.15M NaCl, and 10% glycerol.
Stability
For optimal storage, refrigerate the solution at 4°C if the entire vial will be used within 2-4 weeks. For extended storage periods, freeze the solution at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
SDS-PAGE analysis confirms a purity exceeding 95%.
Synonyms
Complement component 8 gamma polypeptide, C8C, complement component C8 gamma chain, MGC142186.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MQKPQRPRRP ASPISTIQPK ANFDAQQFAG TWLLVAVGSA CRFLQEQGHR AEATTLHVAP QGTAMAVSTF RKLDGICWQV RQLYGDTGVL GRFLLQARGA RGAVHVVVAE TDYQSFAVLY LERAGQLSVK LYARSLPVSD SVLSGFEQRV QEAHLTEDQI FYFPKYGFCE AADQFHVLDE VRR

Product Science Overview

Introduction

Complement Component 8 (C8) is a crucial part of the complement system, which is an essential component of the innate immune system. The complement system enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism, promotes inflammation, and attacks the pathogen’s cell membrane. C8 is composed of three subunits: alpha (C8α), beta (C8β), and gamma (C8γ). The gamma subunit, also known as Complement Component 8, Gamma (C8G), is one of the three subunits that constitute C8 .

Structure and Function

The C8G subunit belongs to the lipocalin family and is one of the three subunits that make up the C8 protein. C8 is composed of a disulfide-linked C8 alpha-gamma heterodimer and a non-covalently associated C8 beta chain . The gamma subunit is not required for the bactericidal activity of C8 but plays a role in the formation of the membrane attack complex (MAC) on bacterial cell membranes .

Role in Neuroinflammation

Recent studies have revealed an inhibitory role of C8G in neuroinflammation. In patients with Alzheimer’s disease, who exhibit strong neuroinflammation, higher levels of C8G have been found in brain tissue, cerebrospinal fluid (CSF), and plasma . Experiments using recombinant C8G protein and shRNA-mediated knockdown showed that C8G inhibits glial hyperactivation, neuroinflammation, and cognitive decline in acute and chronic animal models of Alzheimer’s disease . Additionally, C8G interacts with sphingosine-1-phosphate receptor 2 (S1PR2) to antagonize the pro-inflammatory action of sphingosine-1-phosphate (S1P) in microglia .

Human Recombinant C8G

Human recombinant C8G is produced in E. coli as a single, non-glycosylated polypeptide chain containing 203 amino acids and having a molecular mass of 22.6 kDa . The recombinant protein is fused to a 21 amino acid His-Tag at the N-terminus and purified by proprietary chromatographic techniques .

Applications and Research

The recombinant C8G protein is used in various research applications, including studies on the complement system, neuroinflammation, and Alzheimer’s disease. The inhibitory role of C8G in neuroinflammation makes it a potential therapeutic target for the treatment of neuroinflammatory diseases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.